In a new job - November 7, 2017
New Director of IR and Corporate Communications at Nuevolution
This is a new position within the company, which has been established to further support a successful execution of the company’s goals including the continuous ambition of strengthening the shareholder base with international and institutional investors, but also and not the least to ensure that Nuevolution keep close bonds with its shareholders, and maintain high […]
Drug Development Pharma - November 7, 2017
Beactica makes new investments and appointments
Beactica announces the completion of its latest financing round and the appointments of Erik Walldén and Uli Hacksell to its Board, aiming to strengthen the company’s position in the developing of specialist oncology therapeutics. In addition, Dong-A ST Co., Ltd (170900: Korea SE), the Korean pharmaceutical company and one of Beactica’s collaborators, has become a […]
Drug Development Pharma - November 7, 2017
New Vice President of Oncology R&D at Orion
Professor Heikki Joensuu, M.D., Ph.D., has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation as of 1 December 2017. Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher. Joensuu joins Orion from the Comprehensive Cancer Center, Helsinki University Hospital, where he worked as the Research Director from 2015 to 2017. […]
In a new job - October 25, 2017
The CEO of BioInvent resigns
BioInvent International announces that Michael Oredsson will resign as CEO of BioInvent 31 December 2017. Michael took office as CEO of BioInvent in 2013 to restructure the company and refocus on oncology. Now, both the board and Michael believe that it is a good time for a change in leadership, as the company is transitioning […]
In a new job - October 17, 2017
Torbjörn Wärnheim new member of Moberg Pharma’s management team
Moberg Pharma appoints Torbjörn Wärnheim, Director Pharmaceutical Innovation and Development, as a member of Moberg’s Management Team. Wärnheim has had this position at Moberg Pharma since 2013. Prior to his position with Moberg, Torbjörn Wärnheim was Vice President R&D at Fresenius Kabi. In addition to this he has held senior level positions at ACO HUD […]
In a new job - October 17, 2017
Peter Sackey is new CMO of Sedana Medical
Sedana Medical announces the recruitment of Peter Sackey, MD, PhD as Chief Medical Officer (CMO). Sackey has over twenty years’ clinical experience as an anesthesiologist and ICU physician and has been recruited from a position as Senior Consultant and Associate Professor at the Department of Intensive Care Medicine, Perioperative Medicine and Intensive Care, Karolinska University […]
